» Articles » PMID: 36047015

Estimating Incidence Rates of Periprosthetic Joint Infection After Hip and Knee Arthroplasty for Osteoarthritis Using Linked Registry and Administrative Health Data

Overview
Journal Bone Joint J
Date 2022 Sep 1
PMID 36047015
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The aim of this study was to estimate the 90-day periprosthetic joint infection (PJI) rates following total knee arthroplasty (TKA) and total hip arthroplasty (THA) for osteoarthritis (OA).

Methods: This was a data linkage study using the New South Wales (NSW) Admitted Patient Data Collection (APDC) and the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), which collect data from all public and private hospitals in NSW, Australia. Patients who underwent a TKA or THA for OA between 1 January 2002 and 31 December 2017 were included. The main outcome measures were 90-day incidence rates of hospital readmission for: revision arthroplasty for PJI as recorded in the AOANJRR; conservative definition of PJI, defined by T84.5, the PJI diagnosis code in the APDC; and extended definition of PJI, defined by the presence of either T84.5, or combinations of diagnosis and procedure code groups derived from recursive binary partitioning in the APDC.

Results: The mean 90-day revision rate for infection was 0.1% (0.1% to 0.2%) for TKA and 0.3% (0.1% to 0.5%) for THA. The mean 90-day PJI rates defined by T84.5 were 1.3% (1.1% to 1.7%) for TKA and 1.1% (0.8% to 1.3%) for THA. The mean 90-day PJI rates using the extended definition were 1.9% (1.5% to 2.2%) and 1.5% (1.3% to 1.7%) following TKA and THA, respectively.

Conclusion: When reporting the revision arthroplasty for infection, the AOANJRR substantially underestimates the rate of PJI at 90 days. Using combinations of infection codes and PJI-related surgical procedure codes in linked hospital administrative databases could be an alternative way to monitor PJI rates.Cite this article:  2022;104-B(9):1060-1066.

Citing Articles

Treatment Options of Prosthetic Joint Infections Following Total Ankle Arthroplasty: A Systematic Review.

Capece G, Di Gialleonardo E, Comisi C, Bocchino G, Cinelli V, Mascio A J Clin Med. 2025; 14(3).

PMID: 39941388 PMC: 11818539. DOI: 10.3390/jcm14030718.


Eicosapentaenoic Acid and Docosahexaenoic Acid as an Antimicrobial Agent in Orthopedics-An In Vitro Study About the Race for Surface.

Spiegel C, Unalan B, Kaserbacher A, Arora R, Coraca-Huber D Pathogens. 2025; 14(1).

PMID: 39861018 PMC: 11768219. DOI: 10.3390/pathogens14010057.


The incidence and risk factors of intraoperative bacterial contamination in primary total knee arthroplasty.

Xing L, Liu F, Li E, Kang Y, Tan K, Li J Front Surg. 2024; 11:1458403.

PMID: 39583552 PMC: 11582028. DOI: 10.3389/fsurg.2024.1458403.


Postoperative decrease in serum albumin as predictor of early acute periprosthetic infection after total knee arthroplasty.

Ishii Y, Noguchi H, Sato J, Takahashi I, Ishii H, Ishii R J Orthop Surg Res. 2024; 19(1):670.

PMID: 39420372 PMC: 11488267. DOI: 10.1186/s13018-024-05166-0.


Efficacy and safety of vancomycin for local application in the prevention of surgical site infection after joint arthroplasty: a systematic review and meta-analysis.

Xie C, Zhang L, Zhang D, Tao L, Zhao Y, Luo H EFORT Open Rev. 2024; 9(10):953-968.

PMID: 39360795 PMC: 11457809. DOI: 10.1530/EOR-23-0023.


References
1.
Nembrini S, Konig I, Wright M . The revival of the Gini importance?. Bioinformatics. 2018; 34(21):3711-3718. PMC: 6198850. DOI: 10.1093/bioinformatics/bty373. View

2.
Edwards N, Varnum C, Nelissen R, Overgaard S, Pedersen A . The association between socioeconomic status and the 30- and 90-day risk of infection after total hip arthroplasty : a registry-based cohort study of 103,901 patients with osteoarthritis. Bone Joint J. 2022; 104-B(2):221-226. DOI: 10.1302/0301-620X.104B2.BJJ-2021-1030.R1. View

3.
Peel T, Dowsey M, Buising K, Liew D, Choong P . Cost analysis of debridement and retention for management of prosthetic joint infection. Clin Microbiol Infect. 2012; 19(2):181-6. DOI: 10.1111/j.1469-0691.2011.03758.x. View

4.
Springer B, Cahue S, Etkin C, Lewallen D, McGrory B . Infection burden in total hip and knee arthroplasties: an international registry-based perspective. Arthroplast Today. 2017; 3(2):137-140. PMC: 5485227. DOI: 10.1016/j.artd.2017.05.003. View

5.
Kandel C, Jenkinson R, Widdifield J, Hansen B, Davey J, Muller M . Identification of prosthetic hip and knee joint infections using administrative databases-A validation study. Infect Control Hosp Epidemiol. 2020; 42(3):325-330. DOI: 10.1017/ice.2020.449. View